British pharmaceutical company AstraZeneca said Tuesday it has named Rich Fante president of its U.S. business.
Fante replaces Tony Zook, who was recently named president of MedImmune, a biologics business owned by AstraZeneca. Zook also is chief executive officer of AstraZeneca North America and head of global marketing.
Fante previously led marketing strategies for all AstraZeneca brands in the United States as vice president of brand strategy and portfolio operations.
No comments:
Post a Comment